{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:15:33Z","timestamp":1787890533070,"version":"build-2784847793"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T00:00:00Z","timestamp":1617321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T00:00:00Z","timestamp":1617321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007123","name":"Stanley Medical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007123","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Bipolar Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The Stanley Foundation Bipolar Treatment Outcome Network (SFBN) recruited more than 900 outpatients from 1995 to 2002 from 4 sites in the United States (US) and 3 in the Netherlands and Germany (abbreviated as Europe). When funding was discontinued, the international group of investigators continued to work together as the Bipolar Collaborative Network (BCN), publishing so far 87 peer-reviewed manuscripts. On the 25th year anniversary of its founding, publication of a brief summary of some of the major findings appeared appropriate. Important insights into the course and treatment of adult outpatients with bipolar disorder were revealed and some methodological issues and lessons learned will be discussed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The illness is recurrent and pernicious and difficult to bring to a long-term remission. Virtually all aspects of the illness were more prevalent in the US compared to Europe. This included vastly more patients with early onset illness and those with more psychosocial adversity in childhood; more genetic vulnerability; more anxiety and substance abuse comorbidity; more episodes and rapid cycling; and more treatment non-responsiveness.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The findings provide a road map for a new round of much needed clinical treatment research studies. They also emphasize the need for the formation of a new network focusing on child and youth onset of mood disorders with a goal to achieve early precision diagnostics for intervention and prevention in attempting to make the course of bipolar illness more benign.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40345-020-00218-w","type":"journal-article","created":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T17:02:47Z","timestamp":1617382967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["25 Years of the International Bipolar Collaborative Network (BCN)"],"prefix":"10.1186","volume":"9","author":[{"given":"Robert M.","family":"Post","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori L.","family":"Altshuler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Kupka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"McElroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Frye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4712-8979","authenticated-orcid":false,"given":"Heinz","family":"Grunze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trisha","family":"Suppes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Paul E.","family":"Keck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem A.","family":"Nolen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,2]]},"reference":[{"key":"218_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1034\/j.1399-5618.1999.10113.x","volume":"1","author":"LL Altshuler","year":"1999","unstructured":"Altshuler LL, et al. Gabapentin in the acute treatment of refractory bipolar disorder. Bipolar Disord. 1999;1:61\u20135. https:\/\/doi.org\/10.1034\/j.1399-5618.1999.10113.x.","journal-title":"Bipolar Disord"},{"key":"218_CR2","doi-asserted-by":"publisher","first-page":"450","DOI":"10.4088\/jcp.08m04191","volume":"70","author":"LL Altshuler","year":"2009","unstructured":"Altshuler LL, et al. Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study. J Clin Psychiatry. 2009;70:450\u20137. https:\/\/doi.org\/10.4088\/jcp.08m04191.","journal-title":"J Clin Psychiatry"},{"key":"218_CR3","doi-asserted-by":"publisher","first-page":"e1178","DOI":"10.1542\/peds.2015-0807","volume":"136","author":"LE Anderson","year":"2015","unstructured":"Anderson LE, Chen ML, Perrin JM, Van Cleave J. Outpatient visits and medication prescribing for us children with mental health conditions. Pediatrics. 2015;136:e1178-1185. https:\/\/doi.org\/10.1542\/peds.2015-0807.","journal-title":"Pediatrics"},{"key":"218_CR4","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1176\/appi.ajp.2014.14010035","volume":"172","author":"D Axelson","year":"2015","unstructured":"Axelson D, et al. Diagnostic precursors to bipolar disorder in offspring of parents with bipolar disorder: a longitudinal study. Am J Psychiatry. 2015;172:638\u201346. https:\/\/doi.org\/10.1176\/appi.ajp.2014.14010035.","journal-title":"Am J Psychiatry"},{"key":"218_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.eurpsy.2014.10.005","volume":"30","author":"M Bauer","year":"2015","unstructured":"Bauer M, et al. Influence of birth cohort on age of onset cluster analysis in bipolar I disorder. Eur Psychiatry. 2015;30:99\u2013105. https:\/\/doi.org\/10.1016\/j.eurpsy.2014.10.005.","journal-title":"Eur Psychiatry"},{"key":"218_CR6","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1176\/appi.ajp.2009.08101569","volume":"166","author":"B Birmaher","year":"2009","unstructured":"Birmaher B, et al. Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: the Course and Outcome of Bipolar Youth (COBY) study. Am J Psychiatry. 2009;166:795\u2013804. https:\/\/doi.org\/10.1176\/appi.ajp.2009.08101569.","journal-title":"Am J Psychiatry"},{"key":"218_CR7","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.jaac.2018.05.023","volume":"57","author":"B Birmaher","year":"2018","unstructured":"Birmaher B, et al. A risk calculator to predict the individual risk of conversion from subthreshold bipolar symptoms to bipolar disorder I or II in Youth. J Am Acad Child Adolesc Psychiatry. 2018;57:755\u201363. https:\/\/doi.org\/10.1016\/j.jaac.2018.05.023.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"218_CR8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1755-5949.2011.00257.x","volume":"18","author":"CL Bowden","year":"2012","unstructured":"Bowden CL, et al. Aims and results of the NIMH systematic treatment enhancement program for bipolar disorder (STEP-BD). CNS Neurosci Ther. 2012;18:243\u20139. https:\/\/doi.org\/10.1111\/j.1755-5949.2011.00257.x.","journal-title":"CNS Neurosci Ther"},{"key":"218_CR9","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1176\/appi.ajp.160.9.1636","volume":"160","author":"KN Chengappa","year":"2003","unstructured":"Chengappa KN, Kupfer DJ, Frank E, Houck PR, Grochocinski VJ, Cluss PA, Stapf DA. Relationship of birth cohort and early age at onset of illness in a bipolar disorder case registry. Am J Psychiatry. 2003;160:1636\u201342. https:\/\/doi.org\/10.1176\/appi.ajp.160.9.1636.","journal-title":"Am J Psychiatry"},{"key":"218_CR10","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.4088\/JCP.15m10314","volume":"78","author":"PE Croarkin","year":"2017","unstructured":"Croarkin PE, et al. Genetic risk score analysis in early-onset bipolar disorder. J Clin Psychiatry. 2017;78:1337\u201343. https:\/\/doi.org\/10.4088\/JCP.15m10314.","journal-title":"J Clin Psychiatry"},{"key":"218_CR11","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/j.1399-5618.2007.00421.x","volume":"9","author":"A Duffy","year":"2007","unstructured":"Duffy A, Alda M, Crawford L, Milin R, Grof P. The early manifestations of bipolar disorder: a longitudinal prospective study of the offspring of bipolar xparents. Bipolar Disord. 2007;9:828\u201338. https:\/\/doi.org\/10.1111\/j.1399-5618.2007.00421.x.","journal-title":"Bipolar Disord"},{"key":"218_CR12","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1111\/bdi.12831","volume":"21","author":"GL Faedda","year":"2019","unstructured":"Faedda GL, et al. An International Society of Bipolar Disorders task force report: Precursors and prodromes of bipolar disorder. Bipolar Disord. 2019;21:720\u201340. https:\/\/doi.org\/10.1111\/bdi.12831.","journal-title":"Bipolar Disord"},{"key":"218_CR13","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1176\/appi.ajp.2007.06060981","volume":"164","author":"MA Frye","year":"2007","unstructured":"Frye MA, et al. A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression. Am J Psychiatry. 2007;164:1242\u20139. https:\/\/doi.org\/10.1176\/appi.ajp.2007.06060981.","journal-title":"Am J Psychiatry"},{"key":"218_CR14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1176\/appi.ajp.2008.08030322","volume":"166","author":"MA Frye","year":"2009","unstructured":"Frye MA, et al. Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression. Am J Psychiatry. 2009;166:164\u201372. https:\/\/doi.org\/10.1176\/appi.ajp.2008.08030322.","journal-title":"Am J Psychiatry"},{"key":"218_CR15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.4088\/JCP.14m09127","volume":"76","author":"MA Frye","year":"2015","unstructured":"Frye MA, et al. Clinical risk factors and serotonin transporter gene variants associated with antidepressant-induced mania. J Clin Psychiatry. 2015;76:174\u201380. https:\/\/doi.org\/10.4088\/JCP.14m09127.","journal-title":"J Clin Psychiatry"},{"key":"218_CR16","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1001\/archgenpsychiatry.2011.1508","volume":"69","author":"B Geller","year":"2012","unstructured":"Geller B, et al. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Arch Gen Psychiatry. 2012;69:515\u201328. https:\/\/doi.org\/10.1001\/archgenpsychiatry.2011.1508.","journal-title":"Arch Gen Psychiatry"},{"key":"218_CR17","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1399-5618.2010.00791.x","volume":"12","author":"B Geller","year":"2010","unstructured":"Geller B, Tillman R, Bolhofner K, Zimerman B. Pharmacological and non-drug treatment of child bipolar I disorder during prospective eight-year follow-up. Bipolar Disord. 2010;12:164\u201371. https:\/\/doi.org\/10.1111\/j.1399-5618.2010.00791.x.","journal-title":"Bipolar Disord"},{"key":"218_CR18","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4088\/JCP.14m09300","volume":"76","author":"BI Goldstein","year":"2015","unstructured":"Goldstein BI, Schaffer A, Wang S, Blanco C. Excessive and premature new-onset cardiovascular disease among adults with bipolar disorder in the US NESARC cohort. J Clin Psychiatry. 2015;76:163\u20139. https:\/\/doi.org\/10.4088\/JCP.14m09300.","journal-title":"J Clin Psychiatry"},{"key":"218_CR19","doi-asserted-by":"publisher","first-page":"759","DOI":"10.4088\/jcp.v60n1107","volume":"60","author":"H Grunze","year":"1999","unstructured":"Grunze H, Erfurth A, Marcuse A, Amann B, Normann C, Walden J. Tiagabine appears not to be efficacious in the treatment of acute mania. J Clin Psychiatry. 1999;60:759\u201362. https:\/\/doi.org\/10.4088\/jcp.v60n1107.","journal-title":"J Clin Psychiatry"},{"key":"218_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2019.06.013","author":"DM Hafeman","year":"2019","unstructured":"Hafeman DM, et al. Lithium versus other mood-stabilizing medications in a longitudinal study of youth diagnosed with bipolar. J Am Acad Child Adolesc Psychiatry. 2019. https:\/\/doi.org\/10.1016\/j.jaac.2019.06.013.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"218_CR21","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1034\/j.1399-5618.2002.02228.x","volume":"4","author":"B Hummel","year":"2002","unstructured":"Hummel B, et al. Acute antimanic efficacy and safety of oxcarbazepine in an open trial with an on-off-on design. Bipolar Disord. 2002;4:412\u20137. https:\/\/doi.org\/10.1034\/j.1399-5618.2002.02228.x.","journal-title":"Bipolar Disord"},{"key":"218_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/jcpp.13356","author":"SR Jaffee","year":"2020","unstructured":"Jaffee SR, Sligo JL, McAnally HM, Bolton AE, Baxter JM, Hancox RJ. Early-onset and recurrent depression in parents increases risk of intergenerational transmission to adolescent offspring. J Child Psychol Psychiatry. 2020. https:\/\/doi.org\/10.1111\/jcpp.13356.","journal-title":"J Child Psychol Psychiatry"},{"key":"218_CR23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3389\/fncel.2017.00217","volume":"11","author":"YF Jia","year":"2017","unstructured":"Jia YF, et al. Differential SLC1A2 promoter methylation in bipolar disorder with or without addiction. Front Cell Neurosci. 2017;11:217. https:\/\/doi.org\/10.3389\/fncel.2017.00217.","journal-title":"Front Cell Neurosci"},{"key":"218_CR24","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.biopsych.2006.03.056","volume":"60","author":"PE Keck","year":"2006","unstructured":"Keck PE, et al. Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder. Biol Psychiatry. 2006;60:1020\u20132. https:\/\/doi.org\/10.1016\/j.biopsych.2006.03.056.","journal-title":"Biol Psychiatry"},{"key":"218_CR25","first-page":"2229","volume":"261","author":"GL Klerman","year":"1989","unstructured":"Klerman GL, Weissman MM. Increasing rates of depression Jama. 1989;261:2229\u201335.","journal-title":"Increasing rates of depression Jama"},{"key":"218_CR26","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/j.1399-5618.2007.00467.x","volume":"9","author":"RW Kupka","year":"2007","unstructured":"Kupka RW, et al. Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. Bipolar Disord. 2007;9:531\u20135. https:\/\/doi.org\/10.1111\/j.1399-5618.2007.00467.x.","journal-title":"Bipolar Disord"},{"key":"218_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0022-3956(87)90006-9","volume":"21","author":"PW Lavori","year":"1987","unstructured":"Lavori PW, Klerman GL, Keller MB, Reich T, Rice J, Endicott J. Age-period-cohort analysis of secular trends in onset of major depression: findings in siblings of patients with major affective disorder. J Psychiatr Res. 1987;21:23\u201335. https:\/\/doi.org\/10.1016\/0022-3956(87)90006-9.","journal-title":"J Psychiatr Res"},{"key":"218_CR28","first-page":"53","volume":"1","author":"G Leverich","year":"2005","unstructured":"Leverich G, et al. The anticonvulsant zonisamide in bipolar illness: Clinical response and weight loss. Aspects Affect. 2005;1:53\u20136.","journal-title":"Aspects Affect"},{"key":"218_CR29","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1176\/appi.ajp.163.2.232","volume":"163","author":"GS Leverich","year":"2006","unstructured":"Leverich GS, et al. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry. 2006;163:232\u20139. https:\/\/doi.org\/10.1176\/appi.ajp.163.2.232.","journal-title":"Am J Psychiatry"},{"key":"218_CR30","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.jpeds.2006.10.070","volume":"150","author":"GS Leverich","year":"2007","unstructured":"Leverich GS, et al. The poor prognosis of childhood-onset bipolar disorder. J Pediatr. 2007;150:485\u201390. https:\/\/doi.org\/10.1016\/j.jpeds.2006.10.070.","journal-title":"J Pediatr"},{"key":"218_CR31","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40345-018-0140-x","volume":"7","author":"LH Lomholt","year":"2019","unstructured":"Lomholt LH, et al. Mortality rate trends in patients diagnosed with schizophrenia or bipolar disorder: a nationwide study with 20 years of follow-up. Int J Bipolar Disord. 2019;7:6. https:\/\/doi.org\/10.1186\/s40345-018-0140-x.","journal-title":"Int J Bipolar Disord"},{"key":"218_CR32","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1177\/0004867420920365","volume":"54","author":"GS Malhi","year":"2020","unstructured":"Malhi GS, Bell E, Hamilton A, Morris G. Paediatric Bipolar Disorder: prepubertal or premature? Aust N Z J Psychiatry. 2020;54:547\u201350. https:\/\/doi.org\/10.1177\/0004867420920365.","journal-title":"Aust N Z J Psychiatry"},{"key":"218_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/s0165-0327(98)00002-0","volume":"49","author":"SL McElroy","year":"1998","unstructured":"McElroy SL, et al. Olanzapine in treatment-resistant bipolar disorder. J Affect Disord. 1998;49:119\u201322. https:\/\/doi.org\/10.1016\/s0165-0327(98)00002-0.","journal-title":"J Affect Disord"},{"key":"218_CR34","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/j.1399-5618.2007.00488.x","volume":"9","author":"SL McElroy","year":"2007","unstructured":"McElroy SL, et al. A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders. Bipolar Disord. 2007a;9:426\u201334. https:\/\/doi.org\/10.1111\/j.1399-5618.2007.00488.x.","journal-title":"Bipolar Disord"},{"key":"218_CR35","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jad.2006.11.025","volume":"101","author":"SL McElroy","year":"2007","unstructured":"McElroy SL, et al. Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial. J Affect Disord. 2007b;101:275\u201381. https:\/\/doi.org\/10.1016\/j.jad.2006.11.025.","journal-title":"J Affect Disord"},{"key":"218_CR36","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/s0006-3223(99)00316-9","volume":"47","author":"SL McElroy","year":"2000","unstructured":"McElroy SL, et al. Open-label adjunctive topiramate in the treatment of bipolar disorders. Biol Psychiatry. 2000;47:1025\u201333. https:\/\/doi.org\/10.1016\/s0006-3223(99)00316-9.","journal-title":"Biol Psychiatry"},{"key":"218_CR37","doi-asserted-by":"publisher","first-page":"617","DOI":"10.4088\/jcp.v66n0512","volume":"66","author":"SL McElroy","year":"2005","unstructured":"McElroy SL, et al. Open-label adjunctive zonisamide in the treatment of bipolar disorders: a prospective trial. J Clin Psychiatry. 2005;66:617\u201324. https:\/\/doi.org\/10.4088\/jcp.v66n0512.","journal-title":"J Clin Psychiatry"},{"key":"218_CR38","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.jaac.2010.05.017","volume":"49","author":"KR Merikangas","year":"2010","unstructured":"Merikangas KR, et al. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication-Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry. 2010;49:980\u20139. https:\/\/doi.org\/10.1016\/j.jaac.2010.05.017.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"218_CR39","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1176\/appi.ajp.2012.12030401","volume":"170","author":"E Mesman","year":"2013","unstructured":"Mesman E, Nolen WA, Reichart CG, Wals M, Hillegers MH. The Dutch bipolar offspring study: 12-year follow-up. Am J Psychiatry. 2013;170:542\u20139. https:\/\/doi.org\/10.1176\/appi.ajp.2012.12030401.","journal-title":"Am J Psychiatry"},{"key":"218_CR40","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1600-0447.2007.00993.x","volume":"115","author":"WA Nolen","year":"2007","unstructured":"Nolen WA, et al. Tranylcypromine vs lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study. Acta Psychiatr Scand. 2007;115:360\u20135. https:\/\/doi.org\/10.1111\/j.1600-0447.2007.00993.x.","journal-title":"Acta Psychiatr Scand"},{"key":"218_CR41","doi-asserted-by":"publisher","first-page":"e55176","DOI":"10.1371\/journal.pone.0055176","volume":"8","author":"M Nordentoft","year":"2013","unstructured":"Nordentoft M, et al. Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark. Finland and Sweden PLoS One. 2013;8:e55176. https:\/\/doi.org\/10.1371\/journal.pone.0055176.","journal-title":"Finland and Sweden PLoS One"},{"key":"218_CR42","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.biopsych.2004.01.022","volume":"55","author":"RH Perlis","year":"2004","unstructured":"Perlis RH, et al. Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry. 2004;55:875\u201381. https:\/\/doi.org\/10.1016\/j.biopsych.2004.01.022.","journal-title":"Biol Psychiatry"},{"key":"218_CR43","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/bdi.12401","volume":"18","author":"RM Post","year":"2016","unstructured":"Post RM. Epigenetic basis of sensitization to stress, affective episodes, and stimulants: implications for illness progression and prevention. Bipolar Disord. 2016;18:315\u201324. https:\/\/doi.org\/10.1111\/bdi.12401.","journal-title":"Bipolar Disord"},{"key":"218_CR44","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1001\/jama.2018.0322","volume":"319","author":"RM Post","year":"2018","unstructured":"Post RM. Preventing the malignant transformation of bipolar disorder. JAMA. 2018;319:1197\u20138. https:\/\/doi.org\/10.1001\/jama.2018.0322.","journal-title":"JAMA"},{"key":"218_CR45","doi-asserted-by":"publisher","DOI":"10.1590\/1516-4446-2020-0874","author":"RM Post","year":"2020","unstructured":"Post RM. How to prevent the malignant progression of bipolar disorder. Braz J Psychiatry. 2020. https:\/\/doi.org\/10.1590\/1516-4446-2020-0874.","journal-title":"Braz J Psychiatry"},{"key":"218_CR46","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jad.2014.02.006","volume":"160","author":"RM Post","year":"2014","unstructured":"Post RM, et al. More pernicious course of bipolar disorder in the United States than in many European countries: implications for policy and treatment. J AffectDisord. 2014a;160:27\u201333. https:\/\/doi.org\/10.1016\/j.jad.2014.02.006.","journal-title":"J AffectDisord"},{"key":"218_CR47","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1176\/appi.neuropsych.14080204","volume":"27","author":"RM Post","year":"2015","unstructured":"Post RM, et al. Multigenerational positive family history of psychiatric disorders is associated with a poor prognosis in bipolar disorder. J Neuropsychiatry Clin Neurosci. 2015a;27:304\u201310. https:\/\/doi.org\/10.1176\/appi.neuropsych.14080204.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"218_CR48","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.psychres.2013.08.007","volume":"210","author":"RM Post","year":"2013","unstructured":"Post RM, et al. More stressors prior to and during the course of bipolar illness in patients from the United States compared with the Netherlands and Germany. Psychiatry Res. 2013a;210:880\u20136. https:\/\/doi.org\/10.1016\/j.psychres.2013.08.007.","journal-title":"Psychiatry Res"},{"key":"218_CR49","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.4088\/JCP.08m04811yel","volume":"71","author":"RM Post","year":"2010","unstructured":"Post RM, et al. Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder. J Clin Psychiatry. 2010a;71:1176\u201386. https:\/\/doi.org\/10.4088\/JCP.08m04811yel.","journal-title":"J Clin Psychiatry"},{"key":"218_CR50","doi-asserted-by":"publisher","first-page":"370","DOI":"10.4088\/jcp.v66n0314","volume":"66","author":"RM Post","year":"2005","unstructured":"Post RM, et al. Preliminary observations on the effectiveness of levetiracetam in the open adjunctive treatment of refractory bipolar disorder. J Clin Psychiatry. 2005;66:370\u20134. https:\/\/doi.org\/10.4088\/jcp.v66n0314.","journal-title":"J Clin Psychiatry"},{"key":"218_CR51","doi-asserted-by":"publisher","first-page":"e1309","DOI":"10.4088\/JCP.15m09811","volume":"77","author":"RM Post","year":"2016","unstructured":"Post RM, et al. Age at onset of bipolar disorder related to parental and grandparental illness burden. J Clin Psychiatry. 2016a;77:e1309\u201315. https:\/\/doi.org\/10.4088\/JCP.15m09811.","journal-title":"J Clin Psychiatry"},{"key":"218_CR52","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jpsychires.2016.06.008","volume":"81","author":"RM Post","year":"2016","unstructured":"Post RM, et al. Age of onset of bipolar disorder: combined effect of childhood adversity and familial loading of psychiatric disorders. J Psychiatr Res. 2016b;81:63\u201370. https:\/\/doi.org\/10.1016\/j.jpsychires.2016.06.008.","journal-title":"J Psychiatr Res"},{"key":"218_CR53","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.neubiorev.2017.01.022","volume":"74","author":"RM Post","year":"2017","unstructured":"Post RM, et al. More childhood onset bipolar disorder in the United States than Canada or Europe: Implications for treatment and prevention. Neurosci Biobehav Rev. 2017a;74:204\u201313. https:\/\/doi.org\/10.1016\/j.neubiorev.2017.01.022.","journal-title":"Neurosci Biobehav Rev"},{"key":"218_CR54","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00406-018-0934-y","volume":"270","author":"RM Post","year":"2020","unstructured":"Post RM, et al. More assortative mating in US compared to European parents and spouses of patients with bipolar disorder: implications for psychiatric illness in the offspring. Eur Arch Psychiatry Clin Neurosci. 2020a;270:237\u201345. https:\/\/doi.org\/10.1007\/s00406-018-0934-y.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"218_CR55","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/bdi.12268","volume":"17","author":"RM Post","year":"2015","unstructured":"Post RM, et al. Verbal abuse, like physical and sexual abuse, in childhood is associated with an earlier onset and more difficult course of bipolar disorder. Bipolar Disord. 2015b;17:323\u201330. https:\/\/doi.org\/10.1111\/bdi.12268.","journal-title":"Bipolar Disord"},{"key":"218_CR56","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1192\/bjp.bp.105.013045","volume":"189","author":"RM Post","year":"2006","unstructured":"Post RM, et al. Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. Br J Psychiatry. 2006;189:124\u201331. https:\/\/doi.org\/10.1192\/bjp.bp.105.013045.","journal-title":"Br J Psychiatry"},{"key":"218_CR57","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/NMD.0000000000000116","volume":"202","author":"RM Post","year":"2014","unstructured":"Post RM, et al. More medical comorbidities in patients with bipolar disorder from the United States than from the Netherlands and Germany. J Nerv Ment Dis. 2014b;202:265\u201370. https:\/\/doi.org\/10.1097\/NMD.0000000000000116.","journal-title":"J Nerv Ment Dis"},{"key":"218_CR58","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4088\/JCP.12com08136","volume":"74","author":"RM Post","year":"2013","unstructured":"Post RM, Chang K, Frye MA. Paradigm shift: preliminary clinical categorization of ultrahigh risk for childhood bipolar disorder to facilitate studies on prevention. J Clin Psychiatry. 2013b;74:167\u20139. https:\/\/doi.org\/10.4088\/JCP.12com08136.","journal-title":"J Clin Psychiatry"},{"key":"218_CR59","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.jad.2020.03.025","volume":"272","author":"RM Post","year":"2020","unstructured":"Post RM, Goldstein BI, Birmaher B, Findling RL, Frey BN, DelBello MP, Miklowitz DJ. Toward prevention of bipolar disorder in at-risk children: potential strategies ahead of the data. J Affect Disord. 2020b;272:508\u201320. https:\/\/doi.org\/10.1016\/j.jad.2020.03.025.","journal-title":"J Affect Disord"},{"key":"218_CR60","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.4088\/JCP.15m10121","volume":"77","author":"RM Post","year":"2016","unstructured":"Post RM, et al. Further evidence of a cohort effect in bipolar disorder: more early onsets and family history of psychiatric illness in more recent epochs. J Clin Psychiatry. 2016c;77:1043\u20139. https:\/\/doi.org\/10.4088\/JCP.15m10121.","journal-title":"J Clin Psychiatry"},{"key":"218_CR61","doi-asserted-by":"publisher","first-page":"924","DOI":"10.4088\/JCP.11m07396","volume":"73","author":"RM Post","year":"2012","unstructured":"Post RM, et al. Relationship of prior antidepressant exposure to long-term prospective outcome in bipolar I disorder outpatients. J Clin Psychiatry. 2012;73:924\u201330. https:\/\/doi.org\/10.4088\/JCP.11m07396.","journal-title":"J Clin Psychiatry"},{"key":"218_CR62","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/s0165-0327(01)00299-3","volume":"70","author":"RM Post","year":"2002","unstructured":"Post RM, Leverich GS, Fergus E, Miller R, Luckenbaugh D. Parental attitudes towards early intervention in children at high risk for affective disorders. J Affect Disord. 2002;70:117\u201324. https:\/\/doi.org\/10.1016\/s0165-0327(01)00299-3.","journal-title":"J Affect Disord"},{"key":"218_CR63","doi-asserted-by":"publisher","first-page":"864","DOI":"10.4088\/JCP.08m04994yel","volume":"71","author":"RM Post","year":"2010","unstructured":"Post RM, et al. Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood. J ClinPsychiatry. 2010b;71:864\u201372. https:\/\/doi.org\/10.4088\/JCP.08m04994yel.","journal-title":"J ClinPsychiatry"},{"key":"218_CR64","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1046\/j.1399-5618.2003.00065.x","volume":"5","author":"RM Post","year":"2003","unstructured":"Post RM, et al. A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network. Bipolar Disord. 2003;5:396\u2013406. https:\/\/doi.org\/10.1046\/j.1399-5618.2003.00065.x.","journal-title":"Bipolar Disord"},{"key":"218_CR65","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.17r02122","author":"RM Post","year":"2017","unstructured":"Post RM, Rowe M, Kaplan D, Findling RL. A multisymptomatic child with bipolar disorder: how to track and sequence treatment prim care companion. CNS Disord. 2017b. https:\/\/doi.org\/10.4088\/PCC.17r02122.","journal-title":"CNS Disord"},{"key":"218_CR66","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/bdi.12813","volume":"21","author":"RM Post","year":"2019","unstructured":"Post RM, Yatham LN, Vieta E, Berk M, Nierenberg AA. Beyond evidence-based treatment of bipolar disorder: rational pragmatic approaches to management. Bipolar Disord. 2019;21:650\u20139. https:\/\/doi.org\/10.1111\/bdi.12813.","journal-title":"Bipolar Disord"},{"key":"218_CR67","first-page":"391","volume":"55","author":"GS Sachs","year":"1994","unstructured":"Sachs GS, Lafer B, Stoll AL, Banov M, Thibault AB, Tohen M, Rosenbaum JF. A double-blind trial of bupropion versus desipramine for bipolar depression. J Clin Psychiatry. 1994;55:391\u20133.","journal-title":"J Clin Psychiatry"},{"key":"218_CR68","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1111\/j.1530-0277.1999.tb04087.x","volume":"23","author":"SF Stoltenberg","year":"1999","unstructured":"Stoltenberg SF, Hill EM, Mudd SA, Blow FC, Zucker RA. Birth cohort differences in features of antisocial alcoholism among men and women. Alcohol Clin Exp Res. 1999;23:1884\u201391.","journal-title":"Alcohol Clin Exp Res"},{"key":"218_CR69","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/s0165-0327(98)00077-9","volume":"53","author":"T Suppes","year":"1999","unstructured":"Suppes T, et al. Lamotrigine for the treatment of bipolar disorder: a clinical case series. J Affect Disord. 1999;53:95\u20138. https:\/\/doi.org\/10.1016\/s0165-0327(98)00077-9.","journal-title":"J Affect Disord"},{"key":"218_CR70","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1034\/j.1399-5618.2002.01201.x","volume":"4","author":"T Suppes","year":"2002","unstructured":"Suppes T, et al. Tiagabine in treatment refractory bipolar disorder: a clinical case series. BipolarDisord. 2002;4:283\u20139. https:\/\/doi.org\/10.1034\/j.1399-5618.2002.01201.x.","journal-title":"BipolarDisord"},{"key":"218_CR71","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/00004850-200405000-00010","volume":"19","author":"T Suppes","year":"2004","unstructured":"Suppes T, et al. Use of quetiapine in bipolar disorder: a case series with prospective evaluation. Int Clin Psychopharmacol. 2004;19:173\u20134. https:\/\/doi.org\/10.1097\/00004850-200405000-00010.","journal-title":"Int Clin Psychopharmacol"},{"key":"218_CR72","doi-asserted-by":"publisher","first-page":"508","DOI":"10.4088\/jcp.v63n0607","volume":"63","author":"E Vieta","year":"2002","unstructured":"Vieta E, Martinez-Aran A, Goikolea JM, Torrent C, Colom F, Benabarre A, Reinares M. A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers. J Clin Psychiatry. 2002;63:508\u201312. https:\/\/doi.org\/10.4088\/jcp.v63n0607.","journal-title":"J Clin Psychiatry"},{"key":"218_CR73","doi-asserted-by":"publisher","first-page":"673","DOI":"10.2105\/ajph.74.7.673","volume":"74","author":"K Yamaguchi","year":"1984","unstructured":"Yamaguchi K, Kandel DB. Patterns of drug use from adolescence to young adulthood: III Predictors of progression. Am J Public Health. 1984;74:673\u201381. https:\/\/doi.org\/10.2105\/ajph.74.7.673.","journal-title":"Am J Public Health"}],"container-title":["International Journal of Bipolar Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40345-020-00218-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40345-020-00218-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40345-020-00218-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T17:03:01Z","timestamp":1617382981000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalbipolardisorders.springeropen.com\/articles\/10.1186\/s40345-020-00218-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,2]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["218"],"URL":"https:\/\/doi.org\/10.1186\/s40345-020-00218-w","relation":{},"ISSN":["2194-7511"],"issn-type":[{"value":"2194-7511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,2]]},"assertion":[{"value":"20 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients participating in the Stanley Foundation Bipolar Network provided written informed consent and volunteered for the naturalistic follow-up study in which clinical state and medications were prospectively assessed. Ethical approval was granted by the local ethics committees at each of the seven participating academic sites: NIMH Bethesda, the University Hospitals of Los Angeles, Dallas, Cincinnati (all USA), Utrecht (The Netherlands), Freiburg and Munich (both Germany).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors contributed to and approved the final manuscript and gave their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Robert Post has received speaker\u2019s honoraria over the past 3\u00a0years from AstraZeneca, Validus, Sunovion, Takeda, Pamlabs.Ralph Kupka has received honoraria and royalties over the past 3\u00a0years from UpToDate and De Tijdstroom\/Boom publishers.Susan McElroy is a consultant to or member of the scientific advisory boards of Bracket, F. Hoffmann-La Roche Ltd., MedAvante, Mitsubishi TanabePharma America, Myriad, Novo Nordisk, Shire, and Sunovion. She is a principal or co-investigator on studies sponsored by the Allergan, Brainsway, Marriott Foundation, Myriad, National Institute of Mental Health, Novo Nordisk, Shire, and Sunovion. She is also an inventor on United States Patent No. 6,323,236 B2, Use of Sulfamate Derivatives for Treating Impulse Control Disorders, and along with the patent\u2019s assignee, University of Cincinnati, Cincinnati, Ohio, has received payments from Johnson & Johnson, which has exclusive rights under the patent.Mark A. Frye has received grant support from AssureRx, Mayo Foundation,Myriad, National Institute of Alcohol Abuse and Alcoholism (NIAAA), NationalInstitute of Mental Health (NIMH), Pfizer. He has served as a consultant (Mayo) to Janssen, Mitsubishi Tanabe Pharma Corporation, Myriad, Neuralstem Inc., Otsuka American Pharmaceutical, Sunovion, Teva Pharmaceuticals. His employer Mayo Clinic has a financial interest in AssureRX and the technology referenced in this publication\/presentation.Heinz Grunze received grants\/research support, consulting fees and honoraria within the last 3\u00a0years from Gedeon Richter, Janssen-Cilag, and Servier.Trisha Suppes, MD, PhD, in the past 36\u00a0months, has reported: Grants from Merck, National Institute on Drug Abuse, National Institute of Health, VA Cooperative Studies Program, and VA OR&D PRIME Care, Palo Alto Health Sciences, Stanley Medical Research Institute, Pathways Genomics. Consulting fees from Allergan, Inc., Intracellular Therapies, Sunovion Pharmaceuticals, Inc., and Impel NeuroPharma Inc. Honoraria from CME Institute (Physicians Postgraduate Press, Inc.) and CMEology. Royalties from American Psychiatric Association Publishing, Hogrefe Publishing, Jones and Bartlett, and Wolters Kluwer Health (UpToDate). Travel reimbursement from Sunovion Pharmaceuticals, Inc.Paul Keck Jr has been reimbursed for consulting to Otsuka and Lyndra. He is a co- inventor on United States Patent No. 6387956: Shapira NA, Goldsmith TD, Keck, PE Jr. (University of Cincinnati) Methods of treating obsessive\u2013compulsive spectrum disorder comprises the step of administering an effective amount of tramadol to an individual. Filed March 25, 1999; approved May 14, 2002. Dr. Keck has received no financial gain from this patent.W.A. Nolen has received grants from the Netherlands Organisation for Health Research and Development, the European Union; has received honoraria\/speaker\u2019s fees over the past 5\u00a0years from Lundbeck and Aristo Pharma, and has served over the past 5\u00a0years as consultant for Daleco Pharma.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}